Cargando…

Lytic Induction Therapy against Epstein–Barr Virus-Associated Malignancies: Past, Present, and Future

Epstein–Barr virus (EBV) lytic induction therapy is an emerging virus-targeted therapeutic approach that exploits the presence of EBV in tumor cells to confer specific killing effects against EBV-associated malignancies. Efforts have been made in the past years to uncover the mechanisms of EBV laten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yiu, Stephanie Pei Tung, Dorothea, Mike, Hui, Kwai Fung, Chiang, Alan Kwok Shing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465660/ https://www.ncbi.nlm.nih.gov/pubmed/32748879 http://dx.doi.org/10.3390/cancers12082142

Ejemplares similares

Contribution of Epstein–Barr Virus Lytic Proteins to Cancer Hallmarks and Implications from Other Oncoviruses
por: Dorothea, Mike, et al.
Publicado: (2023)

Autophagy-Dependent Reactivation of Epstein-Barr Virus Lytic Cycle and Combinatorial Effects of Autophagy-Dependent and Independent Lytic Inducers in Nasopharyngeal Carcinoma
por: Yiu, Stephanie Pei Tung, et al.
Publicado: (2019)

Intracellular Iron Chelation by a Novel Compound, C7, Reactivates Epstein–Barr Virus (EBV) Lytic Cycle via the ERK-Autophagy Axis in EBV-Positive Epithelial Cancers
por: Yiu, Stephanie Pei Tung, et al.
Publicado: (2018)

Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies
por: Choi, Chung King, et al.
Publicado: (2015)

Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors
por: Hui, Kwai Fung, et al.
Publicado: (2017)

Counteracting survival functions of EBNA3C in Epstein-Barr virus (EBV)-driven lymphoproliferative diseases by combination of SAHA and bortezomib
por: Hui, Kwai Fung, et al.
Publicado: (2018)

Inhibitory Effects of Resveratrol on the Epstein-Barr Virus Lytic Cycle
por: Yiu, Ching-Yi, et al.
Publicado: (2010)

From Conventional to Next Generation Sequencing of Epstein-Barr Virus Genomes
por: Kwok, Hin, et al.
Publicado: (2016)

Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases
por: Hui, Kwai Fung, et al.
Publicado: (2019)

Therapies based on targeting Epstein‐Barr virus lytic replication for EBV‐associated malignancies
por: Li, Hongde, et al.
Publicado: (2018)

The Dual Functions of Andrographolide in the Epstein–Barr Virus-Positive Head-and-Neck Cancer Cells: The Inhibition of Lytic Reactivation of the Epstein–Barr Virus and the Induction of Cell Death
por: Heawchaiyaphum, Chukkris, et al.
Publicado: (2023)

Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus
por: Gorres, Kelly L., et al.
Publicado: (2016)

Functional Implications of Epstein-Barr Virus Lytic Genes in Carcinogenesis
por: Yap, Lee Fah, et al.
Publicado: (2022)

Distribution, Persistence and Interchange of Epstein-Barr Virus Strains among PBMC, Plasma and Saliva of Primary Infection Subjects
por: Kwok, Hin, et al.
Publicado: (2015)

MCAF1 and synergistic activation of the transcription of Epstein–Barr virus lytic genes by Rta and Zta
por: Chang, Li-Kwan, et al.
Publicado: (2010)

The role of Epstein–Barr virus in epithelial malignancies
por: Tsao, Sai-Wah, et al.
Publicado: (2015)

Epstein–Barr Virus: How Its Lytic Phase Contributes to Oncogenesis
por: Rosemarie, Quincy, et al.
Publicado: (2020)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription
por: Ali, Ahmed, et al.
Publicado: (2022)

Parthenolide induces apoptosis and lytic cytotoxicity in Epstein-Barr virus-positive Burkitt lymphoma
por: LI, YUAN, et al.
Publicado: (2012)

Activation of the Epstein–Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli
por: MacNeil, A, et al.
Publicado: (2003)

ZEB1 Regulates the Latent-Lytic Switch in Infection by Epstein-Barr Virus
por: Yu, Xianming, et al.
Publicado: (2007)

Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis
por: Li, Hongde, et al.
Publicado: (2016)

Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
por: Anderson, Abbie G., et al.
Publicado: (2019)

Arsenicals, the Integrated Stress Response, and Epstein–Barr Virus Lytic Gene Expression
por: Lee, Jaeyeun, et al.
Publicado: (2021)

Replication Compartments—The Great Survival Strategy for Epstein–Barr Virus Lytic Replication
por: Sugimoto, Atsuko
Publicado: (2022)

TRIM5α Promotes Ubiquitination of Rta from Epstein–Barr Virus to Attenuate Lytic Progression
por: Huang, Hsiang-Hung, et al.
Publicado: (2017)

CD8(+) immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells
por: Pudney, Victoria A., et al.
Publicado: (2005)

Complexities associated with expression of Epstein–Barr virus (EBV) lytic origins of DNA replication
por: Xue, Shao-An, et al.
Publicado: (2007)

A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells
por: Ersing, Ina, et al.
Publicado: (2017)

Pseudouridylation of Epstein-Barr virus noncoding RNA EBER2 facilitates lytic replication
por: Henry, Belle A., et al.
Publicado: (2022)

Inhibition of Poly(ADP-ribose)polymerase impairs Epstein Barr Virus lytic cycle progression
por: Mattiussi, Stefania, et al.
Publicado: (2007)

The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis
por: Morales-Sánchez, Abigail, et al.
Publicado: (2018)

Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps
por: Keck, Kristin M., et al.
Publicado: (2017)

PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter
por: Lupey-Green, Lena N., et al.
Publicado: (2017)

Subclinical Epstein-Barr Virus Primary Infection and Lytic Reactivation Induce Thyrotropin Receptor Autoantibodies
por: Tamoto, Naohiro, et al.
Publicado: (2019)

Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein–Barr Virus
por: Deng, Yun, et al.
Publicado: (2021)

Andrographolide Inhibits Lytic Reactivation of Epstein-Barr Virus by Modulating Transcription Factors in Gastric Cancer
por: Malat, Praphatson, et al.
Publicado: (2021)

The Microenvironment in Epstein–Barr Virus-Associated Malignancies
por: Tan, Geok Wee, et al.
Publicado: (2018)

Epstein-Barr virus at 50—future perspectives
por: Young, Lawrence S.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1ml7v5tcmtmhpk8leqbice7sq0